Dr. Tsokos is conducting research to explore the molecular origin of the multiple immune cell abnormalities in lupus, and to identify novel biomarkers for diagnosis and therapeutic targets for treatment.
Dr. Eliza Chakravarty is conducting research to advance understanding of immunological changes of pregnancies in women with lupus to gain insight and improve outcomes.
Dr. Diane Kamen is investigating whether microbes in the gut are capable of contributing to the development of lupus in African Americans with a genetic predisposition for the disease.
The Lupus Nephritis Trials Network (LNTN) is a worldwide organization that brings researchers together with the shared goal of improving outcomes for patients with lupus nephritis.
Dr. Stacy P. Ardoin's research will help determine whether levels of microRNA in the urine can indicate lupus nephritis-related disease activity and damage in the kidneys of children with lupus.
The Lupus Foundation of America Corporate Advisory Council provides industry perspective helping identify and address barriers to lupus drug development.
Dr. Laura Lewandowski is conducting a study that will help to better understand the burden of pediatric lupus and the role of race in lupus severity.
LFA-REAL is a two part system, based on a series of simple questions and observations, to determine a treatment’s impact on the patient’s health and daily life.